AbbVie
ABBV
ABBV
2,220 hedge funds and large institutions have $82.6B invested in AbbVie in 2020 Q1 according to their latest regulatory filings, with 145 funds opening new positions, 1,008 increasing their positions, 837 reducing their positions, and 134 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
2,220
Holders Change
-20
Holders Change %
-0.89%
% of All Funds
49.04%
Holding in Top 10
150
Holding in Top 10 Change
+37
Holding in Top 10 Change %
+32.74%
% of All Funds
3.31%
New
145
Increased
1,008
Reduced
837
Closed
134
Calls
$1.4B
Puts
$1.75B
Net Calls
-$350M
Net Calls Change
+$104M
Top Buyers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$1.13B |
| 2 |
Janus Henderson Group
London,
United Kingdom
|
+$397M |
| 3 |
JPMorgan Chase & Co
New York
|
+$342M |
| 4 |
Bank of New York Mellon
New York
|
+$265M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$231M |
